Research & Developement Services

OM Pharma wants to become a global leader in the development of microbial-derived immunotherapeutics. The immunotherapeutic products should help to fight acute and chronic immunological disorders resulting from infections and inflammation. Building on a strong knowledge and heritage, the main R&D stream focuses on two pillars which are to treat or prevent such diseases.